Preparation method of N-fluorenylmethoxycarbonyl-S-acetamidomethyl-L-penicillamine

By condensing L-penicillamine with N-hydroxymethylacetamide and protecting the amino group, combined with recrystallization purification, the preparation problem of N-fluorenylmethoxycarbonyl-S-acetaminomethyl-L-penicillamine was solved, realizing an efficient, safe and environmentally friendly preparation method with high product yield and purity, suitable for scale-up production.

CN119039194APending Publication Date: 2024-11-29SUZHOU ZHENGJI PHARM RES CO LTD
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202411156962.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-22
Publication Date
2024-11-29

AI Technical Summary

Technical Problem

The lack of an effective method for preparing N-fluorenylmethoxycarbonyl-S-acetaminomethyl-L-penicillamine in the existing technology limits the synthesis and application of integrins.

Method used

L-Penicillamine was condensed with N-hydroxymethylacetamide to generate L-Pen(Acm)-OH, which was then amino-protected with Fmoc-Osu. High-purity N-fluorenylmethoxycarbonyl-S-acetaminomethyl-L-penicillamine was obtained by recrystallization purification under specific solvent and temperature control.

Benefits of technology

The efficient, safe, and environmentally friendly preparation of N-fluorenylmethoxycarbonyl-S-acetaminomethyl-L-penicillamine was achieved, with high product yield and purity, simple operation, and easy scale-up production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005005268080000011
    Figure BDA0005005268080000011
  • Figure BDA0005005268080000012
    Figure BDA0005005268080000012
  • Figure BDA0005005268080000021
    Figure BDA0005005268080000021
Patent Text Reader

Abstract

The invention discloses a preparation method of N-(fluorenylmethoxycarbonyl)-S-acetamidomethyl-L-penicillamine, and relates to a preparation method of N-(fluorenylmethoxycarbonyl)-S- According to the method, L-penicillamine and N-hydroxymethyl acetamide are used as starting raw materials, the raw materials are easy to obtain, toxic and harmful reagents and special equipment are not used, the method is safe and environmentally friendly, the product yield and purity are high, the product quality is stable and controllable, operation is easy and convenient, and large-scale preparation is easy.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a method for preparing N-Fmoc-S-acetylaminomethyl-L-penicillamine, and in particular to a method for preparing N-Fmoc-S-acetylaminomethyl-L-penicillamine with high reaction efficiency and high product quality. Background Art

[0002] Integrins are non-covalently bound α / β heterodimeric cell surface receptors that participate in many cellular processes ranging from cell adhesion and migration to gene regulation. Differential expression of integrins can modulate the adhesion properties of cells, allowing different populations of leukocytes to be recruited to specific organs in response to different inflammatory signals. If left unchecked, integrin-mediated adhesion processes can lead to chronic inflammation and autoimmune diseases. Specific inhibitors of integrin-ligand interactions are effective anti-inflammatory agents for the treatment of various autoimmune diseases, for example, α4 integrins α4β1 and α4β7 play an important role in lymphocyte migration throughout the gastrointestinal tract, while monoclonal antibodies that exhibit high binding affinity to α4β7 have shown therapeutic effects on gastrointestinal autoinflammatory / autoimmune diseases such as Crohn's disease and ulcerative colitis.

[0003] N-Fluorenylmethoxycarbonyl-S-acetylaminomethyl-L-penicillamine (molecular formula: C 23 H 26 N2O5S, English name: (2R)-3-(Acetamidomethylsulfanyl)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-methylbutanoic acid) is an important fragment of synthetic integrin. There is currently no effective and scientific preparation method, which limits the preparation and application of synthetic integrin.

[0004] Summary of the invention

[0005] Purpose of the invention: The present invention aims to provide a method for preparing N-fluorenylmethoxycarbonyl-S-acetylaminomethyl-L-penicillamine which is universal, efficient, convenient and economical.

[0006] Technical solution: The preparation method of N-fluorenylmethoxycarbonyl-S-acetylaminomethyl-L-penicillamine of the present invention comprises the following steps:

[0007] (1) L-penicillamine 3 and N-hydroxymethylacetamide 4 are condensed to obtain L-Pen(Acm)-OH 2:

[0008]

[0009] (2) Compound 2 is protected by Fmoc-Osu amino group to obtain the N-fluorenylmethoxycarbonyl-S-acetylaminomethyl-L-penicillamine 1:

[0010]

[0011] Preferably, the catalyst for the condensation reaction in step (1) is concentrated hydrochloric acid, and the molar ratio of concentrated hydrochloric acid to compound 4 is 1:(2-3).

[0012] More preferably, in step (1), the molar ratio of compound 4, compound 3 and concentrated hydrochloric acid is 1:1.1:(2-3).

[0013] More preferably, the molar ratio of compound 4, compound 3 and concentrated hydrochloric acid is 1:1.1:2.5.

[0014] Preferably, the reaction temperature of the condensation reaction in step (1) is 25-30°C.

[0015] Preferably, the reaction temperature of the amino protection reaction in step (2) is 15-25°C.

[0016] Preferably, after the reaction in step (2) is completed, post-treatment is performed, and the post-treatment method is as follows:

[0017] a. After the reaction is completed, filter and add dichloromethane to the filtrate to adjust the pH to 2-4, separate the layers, and extract the aqueous phase with dichloromethane;

[0018] b. Combine the organic phases, wash with citric acid and NaCl, dry, filter, and concentrate the filtrate;

[0019] c. Add ethanol, heat up and stir to dissolve, cool down and add seed crystals, and continue to cool down and crystallize;

[0020] d. Filter, wash with ethanol, and dry to obtain a crude product of N-fluorenylmethoxycarbonyl-S-acetylaminomethyl-L-penicillamine (Compound 1).

[0021] Preferably, the method for preparing N-fluorenylmethoxycarbonyl-S-acetylaminomethyl-L-penicillamine of the present invention further comprises recrystallization purification, and the recrystallization solvent is selected from a mixed solvent of acetone-n-heptane, acetone-water, and dichloromethane-n-heptane.

[0022] More preferably, the recrystallization solvent is selected from a mixed solvent of acetone-n-heptane.

[0023] More preferably, the mass ratio of acetone to n-heptane is (2-4):(5-30).

[0024] More preferably, the mass ratio of acetone to the crude compound 1 is (2-4):1.

[0025] Still more preferably, the mass ratio of acetone to the crude compound 1 is 3:1.

[0026] More preferably, the mass ratio of n-heptane to the crude compound 1 is (5-30):1.

[0027] Still more preferably, the mass ratio of n-heptane to the crude compound 1 is (9-27):1.

[0028] Still more preferably, the mass ratio of n-heptane to the crude compound 1 is (18-27):1.

[0029] Most preferably, the mass ratio of n-heptane to the crude compound 1 is 18:1.

[0030] Still more preferably, n-heptane is added in batches, first adding 15% to 20% of the total mass, and then adding the remainder.

[0031] Most preferably, n-heptane is added in batches, first adding 1 / 6 of the total mass, and then adding the remainder.

[0032] Preferably, the method of recrystallization is as follows:

[0033] Acetone was added to the crude product of N-Fmoc-S-acetylaminomethyl-L-penicillamine (Compound 1), and the temperature was raised to dissolve. A portion of n-heptane was added, and the temperature was lowered to crystallize after the addition was completed. The remaining amount of n-heptane was added, and the temperature was continued to be lowered to crystallize, and the product of N-Fmoc-S-acetylaminomethyl-L-penicillamine (Compound 1) was obtained by filtering and drying.

[0034] Beneficial effects: Compared with the prior art, the present invention has the following significant advantages:

[0035] The synthetic method designed by the invention has readily available raw materials, does not use toxic and harmful reagents and special equipment, is safe and environmentally friendly, has high product yield and purity, has stable and controllable product quality, is simple to operate, and is easy to scale up for preparation. BRIEF DESCRIPTION OF THE DRAWINGS

[0036] Figure 1 The final product prepared in Example 1 1 H-NMR spectrum;

[0037] Figure 2 This is the purity detection spectrum of the final product prepared in Example 1. DETAILED DESCRIPTION

[0038] The technical solution of the present invention is further described below by way of embodiments.

[0039] Example 1

[0040] (1) Synthesis of L-Pen(Acm)-OH (Compound 2)

[0041] Add 10.0g (67.0mmol) L-penicillamine, 6.6g (73.7mmol) N-hydroxymethylacetamide, and 20.0g water to the reaction bottle, cool to -5~5℃ and stir. Control the temperature ≤10℃, add 17.0g (167.5mmol) concentrated hydrochloric acid dropwise, add, heat to 25~30℃ and stir for 2h. After the reaction is completed, cool to 0~10℃, add 12.8g sodium bicarbonate and then add 37.9g ​​saturated sodium bicarbonate solution dropwise, adjust pH=6.0~7.0, add activated carbon for decolorization, filter to obtain 125.0g L-Pen(Acm)-OH (Compound 2) aqueous solution, the yield is calculated as 100%, purity: 94.40%.

[0042] (2) Synthesis of N-Fluorenylmethoxycarbonyl-S-acetylaminomethyl-L-penicillamine (Compound 1)

[0043] Add 125g L-Pen(Acm)-OH aqueous solution and 118.0g acetone to the reaction bottle, cool to ≤25℃ and stir, add 21.5g (63.7mmol) Fmoc-OSu and 7.8g (73.7mmol) sodium carbonate / 99.0g aqueous solution in turn, stir to dissolve, control the temperature at 15-25℃ and stir for ≥2h. After the reaction is completed, filter and wash the filter cake with 20.0g water. Add 120.0g dichloromethane and 40.0g anhydrous citric acid to the filtrate to adjust the pH to 2-4, separate the layers, add 120.0g dichloromethane to the aqueous phase × 2 to extract and separate the layers, combine the organic phases, wash the organic phases with 66.0g 5% citric acid and 33.0g 15% NaCl × 2 in turn, add sodium sulfate to dry, filter, control the temperature at ≤35℃, and concentrate under reduced pressure until there is basically no distillate. Add 148.0g of ethanol, heat to 45-55℃, stir and dissolve, cool to 30-40℃, add seed crystals and stir for ≥1h, slowly cool to 20-30℃, a large amount of solid precipitates, slowly cool to -5-5℃, stir for ≥12h. Filter, add 30.0g of pre-cooled ethanol to wash the filter cake, and vacuum dry at 35℃ to obtain 20.5g of crude N-fluorenylmethoxycarbonyl-S-acetylaminomethyl-L-penicillamine (Compound 1). Add 13.0g of crude N-fluorenylmethoxycarbonyl-S-acetylaminomethyl-L-penicillamine (Compound 1) and 39.0g of acetone to the reaction bottle, heat to 45-55℃, stir and dissolve. 39.0 g of n-heptane was added dropwise, and the temperature was lowered to 20-30°C after addition. After stirring until a large amount of precipitation occurred, 195.0 g of n-heptane was added, and the temperature was lowered to 0-10°C. Stirring was performed for ≥12 h, and the mixture was filtered and dried under vacuum at 35°C to obtain 11.2 g of N-fluorenylmethoxycarbonyl-S-acetylaminomethyl-L-penicillamine (Compound 1), with a yield of 86.2%. Compound 1 1 H-NMR and HPLC spectra for purity detection are shown in Figure 1-2 .

[0044] Example 2: Screening of preparation parameters of L-Pen(Acm)-OH (Compound 2)

[0045] The operation was carried out according to step (1) of Example 1, and the equivalents of concentrated hydrochloric acid were 2.0 eq, 2.5 eq, and 3.0 eq of compound 4, respectively, and other operating conditions were the same. The reaction purity results of L-Pen(Acm)-OH (compound 2) are shown in Table 1.

[0046] Table 1 Screening results of preparation parameters of compound 2

[0047] Concentrated hydrochloric acid equivalent (eq) Reaction purity (%) 2.0 91.06 2.5 94.96 3.0 94.39

[0048] As can be seen from Table 1, the parameters selected in the present invention are conducive to improving the purity of the intermediate step product, and thus are conducive to controlling the purity of the final product.

[0049] Example 3: Screening of recrystallization system

[0050] The operation was carried out according to Example 1, except that the recrystallization systems in step (2) were acetone / n-heptane, acetone / water, and dichloromethane / n-heptane, respectively, and the other operating conditions were the same. The yield and purity of N-fluorenylmethoxycarbonyl-S-acetylaminomethyl-L-penicillamine (Compound 1) obtained using different recrystallization systems are shown in Table 2.

[0051] Table 2 Screening results of recrystallization parameters

[0052] Crystallization system purity(%) Yield (%) Acetone / n-heptane 99.86 80.5 Acetone / Water 99.31 79.5 Dichloromethane / n-heptane 99.84 77.4

[0053] As can be seen from Table 2, the recrystallization system selected by the present invention can effectively purify and retain the product, and the method is effective and controllable.

[0054] Example 4: Screening of recrystallization parameters

[0055] The operation was carried out in accordance with Example 1, except that the mass of acetone / n-heptane solvent in step (2) was 3w / 9w, 3w / 18w, and 3w / 27w respectively (based on the mass of the crude product of N-fluorenylmethoxycarbonyl-S-acetylaminomethyl-L-penicillamine (Compound 1) as w), and other operating conditions were the same. The yield and purity of N-fluorenylmethoxycarbonyl-S-acetylaminomethyl-L-penicillamine (Compound 1) are shown in Table 3.

[0056] Table 3 Screening results of recrystallization parameters

[0057] Solvent quality purity(%) Yield (%) 3w / 9w 99.18 86.1 3w / 18w 99.31 88.7 3w / 27w 99.23 89.0

[0058] As can be seen from Table 3, the recrystallization parameters selected by the present invention can effectively purify and further improve the product yield, and the method is effective and controllable.

Claims

1. A method for preparing N-Fmoc-S-acetylaminomethyl-L-penicillamine, characterized in that: The following steps are involved: (1) L-penicillamine 3 and N-hydroxymethylacetamide 4 are condensed to obtain L-Pen(Acm)-OH 2: (2) Compound 2 is protected by Fmoc-Osu amino group to obtain the N-fluorenylmethoxycarbonyl-S-acetylaminomethyl-L-penicillamine 1:

2. The preparation method according to claim 1, characterized in that: The catalyst for the condensation reaction in step (1) is concentrated hydrochloric acid, and the molar ratio of concentrated hydrochloric acid to compound 4 is 1:(2-3).

3. The preparation method according to claim 1, characterized in that: The reaction temperature of the condensation reaction in step (1) is 25-30°C.

4. The preparation method according to claim 1, characterized in that: The reaction temperature of the amino protection reaction in step (2) is 15-25°C.

5. The preparation method according to claim 1, characterized in that: The method further comprises recrystallization purification, wherein the solvent for recrystallization is selected from a mixed solvent of acetone-n-heptane, acetone-water, and dichloromethane-n-heptane.

6. The preparation method according to claim 5, characterized in that: The solvent for the recrystallization is selected from a mixed solvent of acetone-n-heptane.

7. The preparation method according to claim 6, characterized in that: The mass ratio of acetone to n-heptane is (2-4):(5-30).

8. The preparation method according to claim 6, characterized in that: The mass ratio of acetone to the crude compound 1 is (2-4):

1.

9. The preparation method according to claim 6, characterized in that: The mass ratio of n-heptane to the crude compound 1 is (9-27):

1.

10. The preparation method according to claim 9, characterized in that: n-heptane is added in batches, first adding 15% to 20% of the total mass, and then adding the remainder.

Citation Information

Cited By

  • Preparation method of high-purity Fmoc-S-trityl-L-penicillamine

    CN122102977A

  • Preparation method of high-purity Fmoc-S-trityl-L-penicillamine

    CN122102977B